As Melanoma/Skin Cancer Detection and Prevention Month, May is the perfect time to encourage people to examine their skin and seek medical assistance if they recognize signs of a melanoma. Early detection and prompt treatment is associated with a much higher survival rate for skin cancer diagnoses.
On May 10, 2017, the U.S. Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab in combination with pemetrexed and carboplatin for the treatment of patients with previously untreated metastatic non-squamous non-small cell lung cancer.
This year the American Nurses Association’s National Nurses Week theme was Nursing: The Balance of Mind, Body, and Spirit. Take time this month to establish new ways to find balance. As nurses we are taught to view the individuals we care for holistically, yet we don’t always care for ourselves with the same focus. Spring is a symbolic time to renew. Take time to learn something new, take actions to renew your spirit, and be mindful of ways to nourish your body. These actions are important for your health and for the health or those you care for.
A study published in Cancer Epidemiology, Biomarkers, and Prevention looking at the ultraviolet radiation exposure and sun protection behaviors among melanoma survivors found that many survivors have room for improvement.
On May 9, 2017, the U.S. Food and Drug Administration (FDA) granted accelerated approval to avelumab for patients with locally advanced or metastatic urothelial carcinoma whose disease progressed during or following platinum-containing chemotherapy or within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.
Chimeric antigen receptor (CAR) T-cell therapy offers options for pediatric patients with relapsed or refractory acute lymphoblastic leukemia, but it comes with a unique set of side effects that can range from mild to severe. As the primary patient providers, oncology nurses are often the first to identify signs and symptoms of adverse events and acute changes in patients’ status. Understanding what to watch for can improve outcomes and help nurses deliver safe, effective care.
Poor cognitive function can cause distress, impact quality of life, and contribute to treatment non-adherence, Catherine Bender, PhD, RN, FAAN, from the University of Pittsburgh, explained during the Distinguished Nurse Researcher session at the 42nd Annual Congress in Denver, CO. She is the 2017 recipient of the Distinguished Nurse Research Award, which recognizes the contributions of a member who has conducted or promoted research that has enhanced the science and practice of oncology nursing.
Advanced practice nurses (APNs) play a role in leadership, policy development, education, and management. As APNs move through their career from novice to expert, ONS can play a large role in professional development.
Chemotherapy-induced nausea and vomiting (CINV) can lead to serious adverse events (AEs) for older adults that could result in hospitalizations. Older adults may be overwhelmed with the amount of information involved with diagnosis and treatment, may not believe their actions will have an impact on symptoms, and tend to adopt a “wait and see” approach to managing AEs. Educational initiatives that tailor symptom management to older adults are necessary to engage and prepare these patients to self-mange CINV at home.
As much of the Northeast received a spring snowstorm, the ONS Board of Directors met face to face in Pittsburgh the second week of March. For this Texas girl, it was a beautiful sight to watch the falling snow as the Board discussed important organizational issues, and I couldn’t help but draw associations between our board governance work and the seasonal work of sowing into programs and reaping the reward of those programs to achieve our organizational vision.